Four teenage girls are recovering after a “targeted” firework attack left them with serious injuries and burns last week, according to NBC affiliate WBBH.
Poly-ICLC is under clinical development by Oncovir and currently in Phase II for Melanoma. According to GlobalData, Phase II drugs for Melanoma have a 27% phase transition success rate (PTSR) ...
Poly-ICLC is under clinical development by Oncovir and currently in Phase II for Solid Tumor. According to GlobalData, Phase II drugs for Solid Tumor have a 37% phase transition success rate (PTSR) ...